地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172469628
传真:18372041646
邮箱:sales@amyjet.com

艾美捷科技特约代理Everest Biotech公司产品。
Everest Biotech公司成立于2000年,该公司主要生产山羊抗体,针对人类、小鼠、大鼠等物种的一系列重要的抗原。另外,Everest Biotech公司已通过ISO 9001:2015认证 (Certificate number CA14829),可靠的质量和个性化的服务,使得客户以遍布全球。
所有来自Everest Biotech的抗体均有以下特性
(1) Everest Biotech自主研发生产
(2)全部经过肽亲和纯化以保证最佳的特异性和纯度;
(3)经过免疫原肽的ELISA和WB实验验证;
(4)PhD科学家团队,提供全方位技术支持服务。
Everest Biotech - Experts in antigen affinity purified goat polyclonal antibodies.
Since 2000, Everest has been producing a catalog containing thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest.
Everest Biotech's commitment to quality and continuous improvement has been recognised with ISO 9001:2015 accreditation (Certificate number CA14829). The customers can be assured they will receive high quality product and excellent customer service.
按疾病种类分:
Allergy
Autoimmunity
Cancer
Cardiovascular
Genetic Disorders
Infectious
Metabolic
Neuronal
按生物功能分:
Adhesion
Apoptosis and its regulation
Autophagy
Cell Cycle and DNA Repair
Chromatin, Histone and RNA regulation
CNS and PNS
Cytoskeletal elements
Embryogenesis and cell differentiation
GAP, GBP, GEF. GRP, GTPase proteins
Inflammation
lectins
Lipids and Sterols Pathways
Mitochondrial proteins
Protein integrity, maturation and break down
Protein Kinases
Protein Phosphatases and Inhibitors
Receptors
SH2 domain containing proteins
SH3 domain containing proteins
Transcriptional regulators
Transcription factors
Translation and its regulation
Transporters, protein sorting, channels
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Everest Biotech"> Everest Biotech
<艾美捷科技代理Box scientific品牌全系列产品
BOX Scientific是一家专注于生命科学领域基于对流的解冻平台的生产商。自2010年在加利福尼亚圣何塞成立以来,BOX Scientific始终致力于程序化样品解冻技术,旨在保持样品完整性、控制过程变异性,并提高临床应用中的数据质量。公司由资深人士Derek Donohue领导,他在制药和基因组诊断领域拥有丰富经验。BOX Scientific的产品以其多功能性、大容量和高速解冻能力,树立了快速、安全和可重复的样品解冻新标准。公司产品包括工位一架解冻站(Station One)、直升机场机架解冻站(Heliport)。

▍BOX Scientific公司产品线
●工位一架解冻站(Station One)
仅使用环境空气即可在极短的时间内解冻冷冻试剂和样品。固定平台设计,实现高通量样品解冻,满足精细样品和试剂的解冻需求。样品和试剂的解冻过程可重复、可程序化,且安全可靠。应用场景:
※适用于需要快速解冻且保持样品完整性的实验室环境。
※特别适用于临床研究和生物样本库管理,确保样品在解冻过程中的稳定性和一致性。
● 直升机场机架解冻站(Heliport)
采用与Station One相同的对流原理,是市场上最大的样品解冻系统。具备自动化集成功能,是首款实现自动化集成的解冻系统。强大的对流系统能将解冻时间缩短多达75%,同时允许解冻后的样品直接无缝过渡到后续自动化流程中。应用场景:
※适用于大规模样品解冻需求,如生物样本库、临床研究机构等。
※特别适用于需要高度自动化和高效解冻的实验室环境,提升整体工作流程的效率和准确性。
▍Box scientific产品列表
<| 货号 | 品名 |
| 1-300-0725 | Station One Rack Thawing Station |
| 1-300-70000 | The Heliport Thawing Station |

艾美捷科技代理Sorachim品牌。
Sorachim公司提供诊断试剂专用酶:脂肪酶、过氧化物酶、尿酸酶,辅酶:NADH、NADPH、NADP;底物:TMB、双甘氨肽等 IVD 行业专用试剂。Sorachim 是一家专注于为制药、生物技术、化妆品和食品行业提供高质量化学原料和定制化解决方案的公司。公司成立于 1986 年,总部位于法国,凭借其广泛的产品组合、严格的质量控制和卓越的客户服务,已成为欧洲化学原料领域的重要供应商之一。Sorachim 的产品广泛应用于药物开发、化妆品配方、食品添加剂和工业应用等领域,包括:
制药原料:Sorachim 提供用于药物开发的化学原料,包括活性药物成分(API)、中间体、辅料和溶剂。
化妆品原料:提供用于化妆品配方的化学原料,如乳化剂、增稠剂、防腐剂和功能性添加剂。
食品添加剂:提供用于食品工业的化学原料,如乳化剂、稳定剂、防腐剂和香料。
工业化学品:公司为工业应用提供特种化学品,如表面活性剂、溶剂、涂料和油墨添加剂。
<< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Sorachim品牌"> 艾美捷科技代理Sorachim品牌

艾美捷科技代理Native Antigen Company品牌。
Native Antigen Company 是一家专注于生产和提供高质量天然抗原的公司。这些抗原广泛应用于疫苗开发、诊断试剂生产和免疫学研究。采用先进的生产和纯化技术,确保抗原的高纯度和高活性;抗原产品广泛应用于疫苗开发、诊断试剂和免疫学研究;提供灵活的定制抗原生产和开发服务,满足客户需求。Native Antigen Company 是传染病试剂主要供应商之一。
其主要产品与服务包括:
(1)天然抗原:提供多种天然抗原,包括病毒蛋白、细菌抗原和寄生虫抗原。
(2)重组蛋白:提供高质量的重组蛋白,用于研究和开发。
(3)诊断试剂:提供用于诊断试剂生产的抗原和抗体。
(4)定制服务:根据客户需求,提供定制化的抗原生产和开发服务。

Premetek公司致力于为学术客户和工业客户提供化学试剂、纳米材料和催化剂,同时也提供多领域的研发服务。通过不断地与业内专业企业进行技术整合,Premetek不断更新产品,并为材料科学和催化领域提供了最多样化和可扩展的选择。
Our retail objectives are to offer the most expansive selection of premium products, provide easy and friendly service, offer the fastest delivery time possible, and ensure that every customer is satisfied with their purchase. Our inventory is determined by extensive market research, attendance at international tradeshows and conferences, customer feedback, and working closely with industry experts and vendors. Premetek is committed to continually improving our services and being the premier online market place for all your needs.
Premetek公司的主要产品包括:
Nanomaterials
Nanomaterial Suspension
Pt,Pd Catalysts -Hydrogenation
Pt,Pd Catalysts -Red/Oxidation
Pt Catalysts - Electrochemistry
Pt Alloy Catalysts - Electrochemistry
Pd Alloy Catalysts - Electrochemistry
Pd,Ru,Ir,Rh,Au Catalysts - Electrochemistry
Fe,Co,Ni,Cu,Ag Catalysts - Electrochemistry
Pt,Pd,Ru,Ir,Rh,Au-Organometallics
Pt, Pd, Rh Homogeneous Catalysts
Custom Products
Special catalysts in stock
| 品名 | 货号 | 规格 |
| Aluminum titanate, Al2TiO5, 40 g each | N10A1000 | 40g |
| Barium strontium titanium oxide, BaSrTi2O6, 40 g each | N10B2000 | 40g |
| Calcium titanate, CaTiO3, 40 g each | N10C1000 | 40g |
| Calcium zirconium titanium oxide, CaZrTi2O3, 40 g each | N10C2000 | 40g |
| Cadmium tungsten oxide, CdWO4, 40 g each | N10C3000 | 40g |
| Cerium aluminate, CeAlO3, 40 g each | N10C4000 | 40g |
| Copper aluminate, CuAl2O4, 40 g each | N10C5000 | 40g |
| Iron nickel oxide, FeNiO4, 40 g each | N10I1000 | 40g |
| Lanthanum chromite, LaCrO3, 40 g each | N10L1000 | 40g |
| Lanthanum manganite , LaMnO3, 40 g each | N10L3000 | 40g |
| Lanthanum substituted lithium titanate, (LaLi3)TiO3, 40 g each | N10L5000 | 40g |
| Lead zirconium substituted titanate, PbZr0.2Ti0.8O3, 40 g each | N10L6000 | 40g |
| Manganese titanate, MnTiO3, 40 g each | N10M1000 | 40g |
| Magnesium aluminate, MgAl2O4, 40 g each | N10M2000 | 40g |
| Nickel cobalt oxide, NiCoO2, 40 g each | N10N1000 | 40g |
| Strontium bismuth niobium oxide, SrBi2Nb2O9, 50 g each | N10S1000 | 40g |
| Strontium ferrite, SrFe12O19, 40 g each | N10S2000 | 40g |
| Yttrium aluminum oxide, Y3Al5O12, 40 g each | N10Y1000 | 40g |
| Yttrium iron oxide, Y3Fe5O12, 40 g each | N10Y2000 | 40g |
| Zinc iron oxide, ZnFe2O4, 40 g each | N10Z1000 | 40g |
| Zinc titanium oxide, ZnTiO3, 40 g each | N10Z2000 | 40g |
| Concentrated Suspension of Nanoscaled Titanium Dioxide (TiO2), 5 kg | N-1000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2010 | 5kg |
| Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3000 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3010 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3020 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3130 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3220 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3230 | 5kg |
| 0.1% Pt on activated carbon powder, 10 g each | P10J1001 | 10g |
| 0.5% Pt on activated carbon powder, 10 g each | P10J1005 | 10g |
| 1.0% Pt on activated carbon powder, 10 g each | P10J1010 | 10g |
| 5.0% Pt on activated carbon powder, 10 g each | P10J1050 | 10g |
| 10% Pt on activated carbon powder, 10 g each | P10J1100 | 10g |
| 20% Pt on activated carbon powder, 10 g each | P10J1200 | 10g |
| 0.1% Pt on granular carbon, 10 g each | P10J2001 | 10g |
| 0.5% Pt on granular carbon, 10 g each | P10J2005 | 10g |
| 1.0% Pt on granular carbon, 10 g each | P10J2010 | 10g |
| 5.0% Pt on granular carbon, 10 g each | P10J2050 | 10g |
| 0.1% Pd on activated carbon powder, 10 g each | P30J1001 | 10g |
| 0.5% Pd on activated carbon powder, 10 g each | P30J1005 | 10g |
| 1.0% Pd on activated carbon powder, 10 g each | P30J1010 | 10g |
| 5.0% Pd on activated carbon powder, 10 g each | P30J1050 | 10g |
| 10% Pd on activated carbon powder, 10 g each | P30J1100 | 10g |
| 20% Pd on activated carbon powder, 10 g each | P30J1200 | 10g |
| 0.1% Pd on granular carbon, 10 g each | P30J2001 | 10g |
| 0.3% Pd on granular carbon, 10 g each | P30J2003 | 10g |
| 0.5% Pd on granular carbon, 10 g each | P30J2005 | 10g |
| 1.0% Pd on granular carbon, 10 g each | P30J2010 | 10g |
| 5.0% Pd on granular carbon, 10 g each | P30J2050 | 10g |
| 0.5% Pd on alumina spheres, 3 mm, SA= | P30L1005 | 10g |
| 1.0% Pd on alumina spheres, 3 mm, SA= | P30L1010 | 10g |
| 0.1% Pt on alumina powder, 10 g each | P10K1001 | 10g |
| 0.5% Pt on alumina powder, 10 g each | P10K1005 | 10g |
| 1.0% Pt on alumina powder, 10 g each | P10K1010 | 10g |
| 5.0% Pt on alumina powder, 10 g each | P10K1050 | 10g |
| 10% Pt on alumina powder, 10 g each | P10K1100 | 10g |
| 20% Pt on alumina powder, 10 g each | P10K1200 | 10g |
| 0.1% Pd on alumina powder, 10 g each | P30K1001 | 10g |
| 0.5% Pd on alumina powder, 10 g each | P30K1005 | 10g |
| 1.0% Pd on alumina powder, 10 g each | P30K1010 | 10g |
| 5.0% Pd on alumina powder, 10 g each | P30K1050 | 10g |
| 10% Pd on alumina powder, 10 g each | P30K1100 | 10g |
| 20% Pd on alumina powder, 10 g each | P30K1200 | 10g |
| 5% Pt on Vulcan XC-72 | P10A050 | 1g/5g |
| 10% Pt on Vulcan XC-72 | P10A100 | 1g/5g |
| 20% Pt on Vulcan XC-72 | P10A200 | 1g/5g |
| 30% Pt on Vulcan XC-72 | P10A300 | 1g/5g |
| 40% Pt on Vulcan XC-72 | P10A400 | 1g/5g |
| 50% Pt on Vulcan XC-72 | P10A500 | 1g/5g |
| 60% Pt on Vulcan XC-72 | P10A600 | 1g/5g |
| 80% Pt on Vulcan XC-72 | P10A800 | 1g/5g |
| Pt Black, High surface area: 40-50 m2/g, Low density: 0.6-0.9 g/ml | P10V010 | 1g/5g |
| 20% Pt on Durable Carbon | P10D200 | 1g/5g |
| 20% Pt on Vulcan XC-72R | P10B200 | 1g/5g |
| 40% Pt on Vulcan XC-72R | P10B400 | 1g/5g |
| 60% Pt on Vulcan XC-72R | P10B600 | 1g/5g |
| 40% Pt on high surface area Ketjenblack | P10E400 | 1g/5g |
| 50% Pt on high surface area Ketjenblack, | P10E500 | 1g/5g |
| 60% Pt on high surface area Ketjenblack | P10E600 | 1g/5g |
| 70% Pt on high surface area Ketjenblack | P10E700 | 1g/5g |
| 5% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A050 | 1g/5g |
| 10% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A100 | 1g/5g |
| 20% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A200 | 1g/5g |
| 30% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A300 | 1g/5g |
| 40% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A400 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72R | P12B600 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A600 | 1g/5g |
| 80% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A800 | 1g/5g |
| Pt-Ru Black (1:1 atomic ratio) | P12V010 | 1g/5g |
| Pt-Ru Black (2.5:1 atomic ratio) | P12V250 | 1g/5g |
| Pt-Ru-Ir Black (1:1:1 atomic ratio) | P124V010 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E600 | 1g/5g |
| 75% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E750 | 1g/5g |
| 20% Pt-Pd (1:3 atomic ratio) on Vulcan XC-72 | P13A203 | 1g/5g |
| 20% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A200 | 1g/5g |
| 20% Pt-Pd (3:1 atomic ratio) on Vulcan XC-72 | P13A230 | 1g/5g |
| 40% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A400 | 1g/5g |
| Pt-Pd Black (1:1 atomic ratio) | P13V010 | 1g/5g |
| Pt-Rh Black (1:1 atomic ratio) | P15V010 | 1g/5g |
| 20% Pt-Ir (1:3 atomic ratio) on Vulcan XC-72 | P14A203 | 1g/5g |
| 20% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A200 | 1g/5g |
| 20% Pt-Ir (3:1 atomic ratio) on Vulcan XC-72 | P14A230 | 1g/5g |
| 40% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A400 | 1g/5g |
| Pt-Ir Black (1:1 atomic ratio) | P14V010 | 1g/5g |
| 20% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA230 | 1g/5g |
| 40% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA430 | 1g/5g |
| 20% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA200 | 1g/5g |
| 40% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA400 | 1g/5g |
| 40% Pt-Fe (3:1 atomic ratio) on Vulcan XC-72 | P1BA430 | 1g/5g |
| 20% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA200 | 1g/5g |
| 20% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA230 | 1g/5g |
| 40% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA400 | 1g/5g |
| 40% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA430 | 1g/5g |
| 60% Pt-Co (3:1 atomic ratio) on Ketjenblack | P1CE630 | 1g/5g |
| 20% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA200 | 1g/5g |
| 20% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA230 | 1g/5g |
| 40% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA400 | 1g/5g |
| 40% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA430 | 1g/5g |
| 60% Pt-Ni (3:1 atomic ratio) on Ketjenblack | P1DE630 | 1g/5g |
| 20% Pt-Cu (1:1 atomic ratio) on Vulcan XC-72 | P1EA200 | 1g/5g |
| 20% Pt-Cu (3:1 atomic ratio) on Vulcan XC-72 | P1EA230 | 1g/5g |
| 20% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA230 | 1g/5g |
| 40% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA430 | 1g/5g |
| 20% Pd-Ir (1:3 atomic ratio) on Vulcan XC-72 | P34A203 | 1g/5g |
| 20% Pd-Ir (1:1 atomic ratio) on Vulcan XC-72 | P34A200 | 1g/5g |
| 20% Pd-Ir (3:1 atomic ratio) on Vulcan XC-72 | P34A230 | 1g/5g |
| 20% Pd-Rh (1:1 atomic ratio) on Vulcan XC-72 | P35A200 | 1g/5g |
| 20% Pd-Rh (3:1 atomic ratio) on Vulcan XC-72 | P35A230 | 1g/5g |
| 20% Pd-Ni (1:1 atomic ratio) on Vulcan XC-72 | P3DA200 | 1g/5g |
| 40% Pd-Au (1:1 atomic ratio) on Ketjenblack | P13E400 | 1g/5g |
| 5% Pd on Vulcan XC-72 | P30A050 | 1g/5g |
| 10% Pd on Vulcan XC-72 | P30A100 | 1g/5g |
| 20% Pd on Vulcan XC-72 | P30A200 | 1g/5g |
| 40% Pd on Vulcan XC-72 | P30A400 | 1g/5g |
| 40% Pd on Ketjenblack | P30E400 | 1g/5g |
| 60% Pd on Vulcan XC-72 | P30A600 | 1g/5g |
| 80% Pd on Vulcan XC-72 | P30A800 | 1g/5g |
| Pd Black, High surface area 40~48 m2/g | P30V010 | 1g/5g |
| 20% Ru on Vulcan XC-72 | P20A200 | 1g/5g |
| 40% Ru on Vulcan XC-72, | P20A400 | 1g/5g |
| Ru Black, High surface area 38~48 m2/g | P20V010 | 1g/5g |
| RuO2 powder, Surface area 18-25 m2/g | P20V020 | 1g/5g |
| 5% Ir on Vulcan XC-72 | P40A050 | 1g/5g |
| 10% Ir on Vulcan XC-72 | P40A100 | 1g/5g |
| 20% Ir on Vulcan XC-72 | P40A200 | 1g/5g |
| 40% Ir on Vulcan XC-72 | P40A400 | 1g/5g |
| Ir Black, High Surface area, 55~65 m2/g, | P40V010 | 1g/5g |
| IrOx powder, conductive, SA:10-20 m2/g | P40V020 | 1g/5g |
| Ru-Ir Black (1:1 atomic ratio) | P24V010 | 1g/5g |
| 20% Rh on Vulcan XC-72 | P50A200 | 1g/5g |
| Rh Black, High surface area 40~50 m2/g | P50V010 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: 4-8 nm) | P60N200 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: ~25 nm) | P60A200 | 1g/5g |
| 30% Au on Vulcan XC-72 (Au particle size: 8 nm) | P60N300 | 1g/5g |
| 40% Au on Vulcan XC-72 (Au particle size: ~35 nm) | P60A400 | 1g/5g |
| 40% Au on Ketjenblack (Au particle size: 4 nm) | P60E400 | 1g/5g |
| 60% Au on Vulcan XC-72 (Au particle size: ~45 nm) | P60A600 | 1g/5g |
| 5% Fe on Vulcan XC-72 | T10A050 | 1g/5g |
| 10% Fe on Vulcan XC-72 | T10A100 | 1g/5g |
| 20% Fe on Vulcan XC-72 | T10A200 | 1g/5g |
| 1% Co on Vulcan XC-72 | T20A010 | 1g/5g |
| 5% Co on Vulcan XC-72 | T20A050 | 1g/5g |
| 10% Co on Vulcan XC-72 | T20A100 | 1g/5g |
| 20% Co on Vulcan XC-72 | T20A200 | 1g/5g |
| 1% Ni on Vulcan XC-72 | T30A010 | 1g/5g |
| 5% Ni on Vulcan XC-72 | T30A050 | 1g/5g |
| 10% Ni on Vulcan XC-72 | T30A100 | 1g/5g |
| 20% Ni on Vulcan XC-72 | T30A200 | 1g/5g |
| 40% Ni on Vulcan XC-72 | T30A400 | 1g/5g |
| 1% Cu on Vulcan XC-72 | T40A010 | 1g/5g |
| 5% Cu on Vulcan XC-72 | T40A050 | 1g/5g |
| 10% Cu on Vulcan XC-72 | T40A100 | 1g/5g |
| 20% Cu on Vulcan XC-72 | T40A200 | 1g/5g |
| 40% Cu on Vulcan XC-72 | T40A400 | 1g/5g |
| 60% Cu on Vulcan XC-72 | T40A600 | 1g/5g |
| 20% Ag on Vulcan XC-72 | P70A200 | 1g/5g |
| 40% Ag on Vulcan XC-72 | P70A400 | 1g/5g |
| 60% Ag on Vulcan XC-72 | P70A600 | 1g/5g |
| 80% Ag on Vulcan XC-72 | P70A800 | 1g/5g |
| Platinum (II) acetylacetonate, 5 g each | P10H110 | 5g |
| (1,5-Cyclooctadiene)dimethylplatinum(II), 1 g each | P10H120 | 1g |
| Dichloro(1,5-cyclooctadiene)platinum(II), 5 g each | P10H130 | 5g |
| Diphenyl(1,5-cyclooctadiene)platinum(II), 5 g each | P10H140 | 5g |
| Trimethylbenzylammoniumhexachloroplatinate (IV), 1 g each | P10H150 | 1g |
| Palladium(II) acetylacetonate, 5 g each | P30H110 | 5g |
| Dichloro(1,5-cyclooctadiene)palladium(II), 5 g each | P30H120 | 5g |
| Hermann's Catalyst, 5 g each | P30H130 | 5g |
| 1,1'-Bis(di-tert-butylphosphino)ferrocene palladium dichloride, 1 g each | P30H140 | 1g |
| Bis(dibenzylideneacetone)palladium(0), 5 g each | P30H150 | 5g |
| Palladium(0) tetrakis(triphenylphosphine), 5 g each | P30H160 | 5g |
| Ruthenium(III) acetylacetonate, 5 g each | P20H110 | 5g |
| Dichloro(1,5-cyclooctadiene)ruthenium(II), polymer, 5 g each | P20H120 | 5g |
| Bis(cyclopentadienyl)ruthenium, 5 g each | P20H130 | 5g |
| Irridium(III) acetylacetonate, 5 g each | P40H110 | 5g |
| Chloro(1,5-cyclooctadiene)iridium(I) dimer, 5 g each | P40H120 | 5g |
| Rhodium(III) acetylacetonate, 5 g each | P50H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 1 g each | P50H120 | 1g |
| Chloro(triphenylphosphine)gold(I), 5 g each | newitem3 | 5g |
| Bromo(triphenylphosphine)gold(I), 5 g each | P60H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Doyledirhodium catalyst-Rh2(5R-MPPIM)4, 1 g | P50-001 | 1g |
| Doyledirhodium catalyst-Rh2(5S-MPPIM)4, 1 g | P50-003 | 1g |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
<艾美捷科技代理Cypex品牌全系列产品
BioIVT作为生命科学和诊断行业的领军企业,专注于提供健康对照与疾病状态样本,包括人和动物的组织或制品、ADME-Tox产品及研究服务、细胞与基因治疗产品、血液及其他生物流体。凭借其在控制和疾病状态样本领域的专注与深耕,BioIVT助力全球科研工作者实现更智能的科学研究,加速医学突破的步伐。

▍Cypex产品线
● 生物体液(血液来源):提供用于生物标志物发现和临床前研究的人和动物全血、血浆、血清及其他血液来源的生物样本。涵盖骨髓、巴菲大衣、脐带血、白磷、经血、血浆和血清、血小板、红细胞、全血等多种样本类型,满足不同研究方向的需求。
● 生物体液(其他):拥有即装即用的库存,包含各种正常的人类和动物生物体液,如胃肠道生物体液、脂肪抽吸液、眼部生物体液、生殖生物体液、呼吸生物液、唾液、Transcellular Fluid、尿等,提供便捷的研究资源。
● 细胞产品:涵盖脂肪细胞、BMMC、细胞提取物、条件介质、解离的肿瘤细胞、内皮细胞、Epithelial Cells、成纤维细胞、HEPATOMUNE培养物、HEPATOPAC培养物、肝细胞、永生化癌细胞系等众多类型,还包含角质形成细胞、黑色素细胞、Musculoskeletal Cells、非实质细胞、眼细胞、PBMC、周细胞、前细胞、纯化免疫细胞亚群、肾细胞、呼吸细胞、皮肤细胞、干细胞、组织来源的免疫细胞、运输产品等,满足不同研究方向需求。
● 外泌体:来源多样:包括血液外泌体(人)、Mesenchymal Stem Cells(人)、人脐带血血清外泌体、人胎盘来源的外泌体、人前细胞外泌体等。提供外泌体批次的广泛表征分析,包括大小和数量测定、表面蛋白表达、miRNA表达与测序、用于蛋白质组学和脂质组学的LS/MS、电子显微镜观察、稳定性测试、特定目标蛋白质的蛋白质印迹以及多种功能测定。
● 培养基/试剂/试剂盒:养提供培养基、血清和即用型试剂盒,满足细胞培养需求。提供ADME培养基/试剂,用于孵育、解冻和接种肝细胞培养,确保实验最佳条件。提供化学药品,包含高质量化学品,如对照细胞色素P450(CYP)底物及其相应的代谢物,用于早期药物发现服务,帮助加快候选药物选择。
● 分子产物:总RNA、总核酸 - 糖尿病、总RNA - 代谢等产品,为基因表达分析、疾病机制研究等提供了高质量的原料。这些核酸产物经过严格的质量控制,确保其纯度和完整性,满足各种分子生物学实验的需求。
● 亚细胞组分和重组酶:包括匀浆、微粒体、S9、胞浆、非CYP重组酶、细胞等。这些亚细胞组分经过精细的分离和纯化工艺,保留了其原有的生物活性和功能。
● 组织:人体组织及动物组织
①人体组织:其ASTERAND®人体组织标本涵盖了皮肤、软组织、、泌尿系统、中枢神经系统、内分泌腺、胃肠、头颈部、肝、淋巴、乳房、肌肉骨骼、生殖、呼吸等多个系统和器官的组织。这些组织标本经过严格的收集和处理流程,确保其质量和可靠性。
②动物组织:提供来自任何市售动物研究模型的动物组织,如大脑、肾脏、肺、肠道、心脏和皮肤等组织类型的定制制剂,为动物模型研究提供了丰富的资源。
▍Cypex部分产品列表
| 品名 | 货号 | 描述 |
| Human Bone Marrow Aspirate | BOV00BMAK2MP | Bovine Bone Marrow Aspirate K2EDTA Pooled Male |
| Human Bone Marrow Aspirate | HUMANBMANH-0043290 | Human Bone Marrow Aspirate NaHep Normal Frozen, 1mL |
| Human Bone Marrow Aspirate | CUSTOMCELL | Human Bone Marrow Aspirate |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0115680 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0105114 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0105116 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0116317 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Male |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0109008 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Male Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP02BMAK2-0121295 | Rhesus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP02BMAK2-0126229 | Rhesus Monkey Bone Marrow Aspirate K2EDTA Male |
| Non-Human Primate Bone Marrow Aspirate | CUSTOMBIOF | Non-Human Primate Bone Marrow Aspirate |
| Mouse Bone Marrow Aspirate | MSE02BMANHP | BALB/C Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | MSE01BMANHP | C57BL/6 Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | MSE00BMANHP | CD-1 (ICR) Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | CUSTOMCELL | Mouse Bone Marrow Aspirate |
| Human Heme-Oncology Bone Marrow | CUSTOMBIOFBLDDS | Human Heme-Oncology Bone Marrow |
| Normal Human Buffy Coat | CUSTOMCELL | Normal Human Buffy Coat |
| Human Cord Blood | HUMANCBCPD-0119137 | Human Cord Blood CPD Female Not Viral Tested Fresh |
| Human Cord Blood | HUMANCBCPD-0119138 | Human Cord Blood CPD Female Viral Negative Fresh |
| Human Cord Blood | HUMANCBPCPD-0129988 | Human Cord Blood Plasma CPD Gender Unspecified, 10mL Frozen |
| Human Cord Blood | HUMANCBS-0129990 | Human Cord Blood Serum Gender Unspecified |
| Human Cord Blood | HUMANCBS-0129989 | Human Cord Blood Serum Gender Unspecified, 1mL Frozen |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX100-0117880 | Human GMP VivoSTART Full Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX100-0109051 | Human GMP VivoSTART Full Pak Gender Unspecified Fresh |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX50-0131914 | Human GMP VivoSTART Half Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX25-0131912 | Human GMP VivoSTART Qtr Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX15B-0131909 | Human GMP VivoSTART XL Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX15B-0131908 | Human GMP VivoSTART XL Gender Unspecified Fresh |

艾美捷科技代理Biorelevant品牌。
Biorelevant公司成立于2006年,位于英国伦敦,是一家专注于开发和生产模拟人体胃肠道环境的体外溶出介质的公司,致力于为制药行业提供更准确、更可靠的药物溶出测试解决方案。Biorelevant公司可提供体外溶出介质:包括多种模拟人体胃肠道环境的溶出介质,用于药物溶出测试;还可以根据客户需求,提供定制化的溶出介质和测试方案并提供全面的技术支持和应用指导,帮助客户优化药物开发和测试流程。Biorelevant产品包括:FaSSIF、FeSSIF、FaSSGF、FeSSGF等多种模拟空腹和饱腹状态的溶出介质。其产品应用范围包括:
(1)药物开发,广泛应用于口服固体制剂的开发和优化,提高生物利用度和疗效;
(2)质量控制,用于药物生产过程中的质量控制,确保产品的一致性和稳定性;
(3)法规提交,支持药物注册和法规提交,提供符合监管要求的溶出测试数据。
<<<< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Biorelevant品牌"> 艾美捷科技代理Biorelevant品牌
<艾美捷科技代理Vectorbiolabs品牌全系列产品
Vector Biolabs是一家专注于提供高质量AAV(腺相关病毒)和腺病毒产品的生物科技公司,总部位于宾夕法尼亚州费城。Vector Biolabs公司提供包括定制病毒载体生产、载体设计、克隆、扩增、包装、纯化和滴度测定在内的服务,并且拥有一个包含超过90,000种针对人类、小鼠和大鼠基因组定制的AAV产品目录,服务于包括生物制药公司和研究机构在内的全球客户。此外,Vector Biolabs 为研究界提供与基因表达、基因编辑和基因沉默相关的服务。

▍Vectorbiolabs公司的产品与服务
● AAV定制生产:根据客户需求,定制生产AAV载体,以满足特定的研究或治疗需求。
● AAV控制产品:提供一系列用于AAV基因治疗的控制产品,确保实验的准确性和可靠性。
● 腺病毒建设与扩增:提供腺病毒的构建和扩增服务,支持客户的病毒载体研究。
● shRNA筛选/验证与产品目录:提供shRNA筛选和验证服务,以及相关的产品目录,帮助客户进行基因沉默研究。
使用AAV进行基因治疗的好处:
①低免疫反应:AAV载体引发免疫反应的可能性较低,适合敏感应用。
②稳定的基因递送:提供非整合基因递送,降低诱变风险。
③可扩展的生产:确保从小规模到大规模的研究和临床试验的可靠供应。
④广泛的治疗应用:多功能性使其成为靶向大脑、肝脏和视网膜等器官的理想选择。
| 特性 | AAV | 腺病毒 (Adenovirus) |
| 基因表达 | 长期、稳定表达 | 快速、瞬时表达 |
| 免疫原性 | 低 | 高 |
| 装载容量 | ~4.7 kb | ~8 kb - 38 kb (大得多) |
| 趋向性/靶向能力 | 高 - 可通过不同衣壳定制 | 广泛,可靶向多种组织 |
| 最佳应用场景 | 体内研究,长期表达 | 体外 & 体内研究,癌症 & 疫苗研究 |
▍Vectorbiolabs部分产品列表
| 品名 | 货号 | AAV Serotype | AAV ITR | Promoter | Reporter | Storage Buffer | Titer | Viral Backbone | Volume (µL) |
| AAV1-LacZ | 7001 | AAV1 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-GFP | 7002 | AAV1 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-LacZ | 7003 | AAV2 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-GFP | 7004 | AAV2 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-LacZ | 7005 | AAV5 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-GFP | 7006 | AAV5 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV9-GFP | 7007 | AAV9 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-GFP | 7008 | AAV6 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-Cre | 7010 | AAV1 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-Cre | 7011 | AAV2 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-Cre | 7012 | AAV5 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-Cre | 7013 | AAV6 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |

艾美捷科技特约代理Cell Biolabs公司产品。
Cell Biolabs公司一直致力于开发生命科学研究领域的技术和工具,并将所开发的创新性技术成果商业化。我们孜孜不倦专注于提供最完善的产品,以期使细胞功能和疾病机制研究领域达到新高度。
Cell Biolabs, Inc. proudly develops and commercializes innovative technologies and tools for life science research. We are committed to providing the best products that facilitate discovery of the mechanisms underlying cell function and disease. Our unique, cutting-edge products are currently used around the world in the research laboratories of universities, government institutes, biotechnology and pharmaceutical companies.
Cell Biolabs公司的主要产品包括:
细胞分析
病毒表达和纯化试剂
氧化应激分析
小G蛋白分析试剂盒和试剂
按照研究领域细分:
Cell Based Assays
Pathogen & Toxin Assays
Cell Signaling & Protein Biology
Stem Cell Research
Metabolism Research
Viral Expression
Oxidative Stress / Damage
Frequently Asked Questions about Cell Biolabs Products
" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Cell Biolabs公司产品"> 艾美捷科技特约代理Cell Biolabs公司产品
<艾美捷科技代理AxisPharm品牌全系列产品
AxisPharm是一家专业的分析服务提供商,致力于为科学研究界和工业界提供高质量的分析服务。凭借先进的仪器设备和专业的技术团队,AxisPharm在生物分析、化学分析和质量控制领域树立了良好的声誉。AxisPharm公司的产品线包括:PEG 连接子、用于药物递送的脂质、荧光染料、单击化学试剂、聚聚乙二醇,共聚物、可裂解的连接子、抗体和抗体药物偶联物ADC、ADC 有效载荷、细胞生物学试剂、脱氧核糖核酸、修饰语、探针、合成肽、目标特定链接器、硫醇反应性接头、酸反应性连接子、胺反应性连接子、羰基反应性连接子、探针、修饰符。

▍AxisPharm产品线
● PEG连接子:聚合物聚乙二醇是多分散聚乙二醇 (PEG) 聚合物,是一种从石油中提取的聚醚化合物,具有从工业制造到医药的许多应用。
● 用于药物递送的脂质:在药物递送系统中起着至关重要的作用,特别是在脂质体、脂质纳米颗粒或脂质胶束等脂质制剂中。脂质提供结构稳定性,增强药物溶解度,实现控释,并促进靶向药物递送。
● 荧光染料:也称为荧光团或荧光探针,是吸收一种波长的光并以更高波长发射的化合物,从而产生可见荧光。它们是生物学研究中的重要工具,用于标记和检测蛋白质、核酸和细胞等生物分子,从而在显微镜、流式细胞术和实时荧光定量 PCR 等应用中实现灵敏和精确的可视化。
● 点击化学试剂:具有高特异性和最少的副产物,简化了复杂的合成过程。因此,它们在分子生物学、材料科学和药物化学中发挥着至关重要的作用。
● 聚合物聚乙二醇:多分散聚乙二醇 (PEG) 聚合物,是一种从石油中提取的聚醚化合物,具有从工业制造到医药的许多应用。
● 可裂解连接子:一类重要的分子,广泛应用于药物发现、化学生物学和材料科学等各个领域。这些连接子充当两个或多个分子实体之间的连接桥,可以在特定条件下选择性地裂解,从而释放附着的分子。这一特性使它们成为生物活性化合物靶向药物递送、成像和控释的有吸引力的工具。
● 抗体及抗体-药物偶联物及细胞生物学试剂:种类丰富可选择。
● ADC有效载荷:作为 ADC 的三个主要成分之一,有效载荷是高活性和有毒的药物分子,通过化学连接子附着在抗体上。有效载荷可以是小分子、蛋白质毒素、生物活性肽、酶,甚至放射性核素。通过适当的接头与适当的载体系统耦合的有效载荷可能会显示出靶向药物递送的特异性和有效性的提高。
● 脱氧核糖核酸:DNA 是脱氧核糖核酸的缩写,是一种包含所有生物体发育和功能的遗传指令的分子。DNA 由四个基本组成部分组成,称为核苷酸,由糖、磷酸基团和含氮碱基组成。
● 改性剂:改变其他分子或材料特性的化合物。在药物研发领域,改性剂在新型药物递送系统和生物医学设备的设计和优化中发挥着至关重要的作用。一种常见的改性剂类型是官能团,它是赋予分子特定化学和物理性质的原子的特定排列。
● 探针:AxisPharm 提供各种靶标特异性探针,例如叶酸 PEG、生物素 PEG、PROTAC PEG、荧光染料探针和图像探针。探针是一类含有官能团的化合物,旨在选择性地与生物分子(如酶、受体和核酸)相互作用。这些官能团包括荧光染料、生物素和亲和标签等,可以检测和定量复杂生物系统中的特定分子。
| Different Types of Polyethylene Glycol PEG Linkers in Stock | ||||
| Acid PEG | Diketone PEG | Non-PEG linker | PFP ester PEG | Sugar PEG β-Glucuronide Linker |
| Aldehyde PEG | DNP PEG | PEG-t-butyl ester | Phosphonate PEG | Sulfonic acid PEG |
| Alkyne PEG | DBCO PEG | PEG-X-PEG | Polymer PEG | TCO PEG |
| Amino PEG | DSPE PEG | Peptide Linkers | Propargyl PEG | Tetrazine PEG |
| Aminooxy PEG | Fluorescent PEG | Lipid PEG | PROTAC Linker | Homobifunctional PEG |
| Azide PEG | Fmoc PEG | M-PEG | Silane PEG | Bromo PEG |
| BCN-PEG | Folate PEG | Maleimide PEG | SPDP PEG | Tosylate PEG |
| Benzyl-PEG | Thiol PEG | MeNH-PEG | Branched PEG | Bis-Sulfone PEG |
| Biotin PEG | Hydrazide PEG | NHS ester PEG | HyNic PEG | DOTA Reagent DOTA PEG |
| Bis-PEG-acid | Hydroxy PEG | Boc-PEG | Bis-PEG-NHS | Iodo PEG |
| Bis-PEG-NHS | Cleavable Linkers | |||
| Lipids for Drug Delivery | ||||
| Biotinyl Cap PE | Dodecanyl PE | Other Lipid | Phosphatidylcholine | Phosphatidylethanolamine |
| Biotinyl PE | Glutaryl PE | PDP PE | Phosphoglycerol | Ptd Thioethanol |
| Caproylamine PE | Ionizable Lipid | PE MCC | Phosphoserine | Succinyl PE |
| Cationic Lipid | Lipid PEG | Cyanur PE | MPB PE | |
| Fluorescent Dye | ||||
| AF Dyes | Cyanine Dyes | MB Dyes | Rhodamine Dye | Rox (carboxy-X-rhodamine) Dye |
| APDye Fluors | DNP PEG | JOE | R6G | Peptide Labeling Reagents |
| Bodipy Probes | Fluorescein (FAM) | Pyrene Probes | TAMRA Dye | Classic Fluorescent Dyes |
| IR Fluors | Quenchers | Coumarin 343 | ||
| Click Chemistry Tools & Reagents | ||||
| Alkyne PEG | BCN-PEG | PTAD Linker | Tetrazine PEG | Click Chemistry Auxiliary Reagents |
| Azide PEG | DBCO PEG | TCO PEG | Methylcyclopropene Linkers | |
| Polymer PEG | ||||
| Acrylate | Biotin | Fmoc | Lipoamide | Silane |
| Active ester | Boc | Folate | Maleimide | Stearic acid |
| Aldehyde | Carboxylic acid | guanlian1010 | MW 2000 | TCO |
| Amine | Cholesterol | Hydrazide | MW 5000 | Thiol |
| Azide | DBCO | Hydroxyl | Polysarcosine | |
| Cleavable Linkers | ||||
| -S-S-Cleavable | PC Cleavable | Disulfide Linkers | Dde Cleavable Linkers | β-Glucuronide Linkers |
| Cleavable Peptide | diazo biotin probes | DTSSP crosslinker | Photocleavable Biotin | |
| Antibody and Antibody Drug Conjugate (ADC) | ||||
| Inotuzumab | Trastuzumab | Enfortumab | Labetuzumab govitecan | Mirvetuximab soravtansine (solution) |
| Vobramitamab | Disitamab | Mirzotamab | Loncastuximab tesirine | Trastuzumab deruxtecan (solution) |
| Polatuzumab | Ozuriftamab | Brentuximab | Trastuzumab deruxtecan | ADC Control Human IgG1-Deruxtecan (DAR 8) |
| Gemtuzumab | Inebilizumab | Datopotamab | Cofetuzumab pelidotin | Glembatumumab vedotin |
| Daratumumab (PBS) | Denintuzumab | Sacituzumab govitecan | Belantamab mafodotin | Trastuzumab duocarmazine |
| Praluzatamab | Naratuximab | Tisotumab | Enfortumab vedotin-ejfv | Trastuzumab emtansine (solution) |
| Lorvotuzumab | Rolinsatamab | Trastuzumab emtansine | Telisotuzumab vedotin | Enfortumab vedotin-ejfv (solution) |
| Izeltabart | Mipasetamab | Datopotamab deruxtecan | Gemtuzumab ozogamicin | Brentuximab vedotin (solution) |
| Lupartumab | Iladatuzumab | ORM-5029 | Cantuzumab ravtansine | Depatuxizumab mafodotin |
| Cantuzumab | Briobacept | Ifinatamab deruxtecan | Tusamitamab ravtansine | ADC Control Human IgG1-Deruxtecan (DAR 4) |
| Lonigutamab | Tamrintamab | Tisotumab vedotin | Zilovertamab vedotin | Depatuxizumab MMAE |
| Moxetumomab | Sacituzumab | Disitamab vedotin | Polatuzumab vedotin | ADC Control Human IgG1-vcMMAF |
| Azintuxizumab | Upifitamab | Belantamab | Pivekimab | Sacituzumab govitecan (solution) |
| Lifastuzumab | Glembatumumab | Patritumab deruxtecan | Farletuzumab ecteribulin | |
| Payloads and Linker modified Payloads | ||||
| Exatecan | Belotecan HCl | SGD-1882 | Dolastatin 10 | MC-Val-Cit-PAB-Doxorubicin |
| SN 38 | Gimatecan | MMAF | Calicheamicin | Gly3-Val-Cit-PAB-MMAE |
| Amrubicin | Taltobulin | Auristatin E | Eribulin Mesylate | SuO-Glu-Val-Cit-PAB-MMAE |
| Mitomycin C | Dxd | Chlorambucil | Soblidotin (Auristatin PE) | Fmoc-G-amino-CH2O acetyl-Exetecan |
| Deruxtecan analog | Lurtotecan | PF-06380101 | Deruxtecan analog 2 | DM1-MCC-PEG3-Biotin |
| sulfo-SPDB-DM4 | Exatecan mesylate | Auristatin F | Paclitaxel | GGFG-amino-CH2O-acetyl Exetecan |
| Rubitecan | MC-DM1 | MMAF-methyl ester | MC-MMD10 | Mal-PEG8-Val-Cit-PAB-MMAE |
| (4-NH2)-Exatecan | Irinotecan | Doxorubicin-SMCC | SPDB-DM4 | DBCO-PEG4-Val-Cit-PAB MMAF |
| Topotecan | PNU-159682 | MMAD | 10-Hydroxycamptothecin | Topotecan Hydrochloride |
| CL2A-SN38 | DM4 | 7-Ethylcamptothecin | ||
| Cell Biology Reagents | ||||
| Neuro-DiO, lipophilic tracer | VU (5-Vinyl-uridine) | CM-DiI, lipophilic tracer | LumiTracker ER Green | ER-Tracker Red (BODIPY TR Glibenclamide) |
| Annexin V-AF 647 conjugate | DAPI, blue fluorescent nucleic acid stain | Propidium Iodide | Deep-Red Fluorescent Nissl Stain | MitoCLox, mitochondrial lipid peroxidation probe |
| Annexin V-AF 488 conjugate | LumiTracker Mito Rhodamine 123 | LumiTracker Mito Green FM | RAPID DiI, lipophilic tracer | Laurdan (6-Dodecanoyl-2-dimethylaminonaphthalene) |
| Annexin V, His Tag | Thiazole Orange | SynaptoProbe® Red | LumiTracker ER Red | Linear Polyacrylamide for Nucleic Acid Precipitation |
| DiD, lipophilic tracer | RH 237, potentiometric probe | SynaptoProbe® Green | RAPID DiO, lipophilic tracer | Fluo-4 AM, green fluorescent calcium indicator |
| DiR, lipophilic tracer | Hoechst 33342, blue fluorescent nucleic acid stain | LumiTracker® Mito Red FM | DiI, lipophilic tracer | YODi-1, green fluorescent nucleic acid stain |
| DNA | ||||
| CPG solid supports | DNA Stains | Modified Triphosphates | phosphoramidite | |
| Probes | ||||
| Biotin PEG | Folate PEG | Image Probes | PROTAC Linker | |
| Amine reactive Linkers | ||||
| Acid PEG | Aldehyde PEG | Bromo PEG | Maleimide PEG | NHS ester PEG |
▍AxisPharm提供的服务
● 蛋白质组学服务:提供质谱分析、蛋白质鉴定和定量服务。专注于生物标志物分析,帮助客户在复杂的生物样本中发现和验证潜在的生物标志物。
● 代谢组学服务:利用先进的LC-MS/MS技术进行代谢物分析,提供通路洞察,帮助客户理解代谢途径和生物过程。
● 高级LC-MS/MS服务:用于PK分析和HPLC分离,确保高精度和高效率的研究结果,提供PK/PD研究,支持药物开发和临床前研究。
▍AxisPharm部分产品列表
| Cat# | Name | M.W. | Purity |
| AP15197 | Exatecan | 435.45 | ≥98% |
| AP15072 | SN 38 | 392.4 | ≥95% |
| AP15226 | Amrubicin | 483.47 | ≥98% |
| AP15664 | Mitomycin C | 334.3 | ≥98% |
| AP15203 | 10-Hydroxycamptothecin | 364.35 | ≥95% |
| AP15204 | 7-Ethylcamptothecin | 376.41 | ≥95% |
| AP15210 | Rubitecan | 393.35 | ≥95% |
| AP15211 | (4-NH2)-Exatecan | 403.43 | ≥95% |
| AP15206 | Topotecan | 421.5 | ≥95% |
| AP15207 | Topotecan Hydrochloride | 425.5 | ≥95% |
| AP15202 | Belotecan HCl | 433.5 | ≥95% |
| AP15208 | Gimatecan | 447.5 | ≥95% |
| AP15227 | Taltobulin | 473.65 | ≥99% |
| AP15201 | Dxd | 493.48 | ≥95% |
| AP15209 | Lurtotecan | 518.56 | ≥95% |
| AP15196 | Exatecan mesylate | 531.55 | ≥98% |
| AP15200 | Deruxtecan analog 2 | 579.58 | ≥95% |
| AP15205 | Irinotecan | 586.68 | ≥95% |
| AP15224 | PNU-159682 | 641.62 | ≥98.24% |
| AP15220 | Soblidotin (Auristatin PE) | 701.98 | ≥95% |
| AP15225 | SGD-1882 | 725.8 | ≥98% |
| AP15213 | MMAF | 732 | ≥95% |
| AP15216 | Auristatin E | 732 | ≥95% |
| AP15311 | Chlorambucil | 304.21 | ≥98 |
| AP15219 | PF-06380101 | 743.01 | ≥95% |
| AP15214 | Auristatin F | 746 | ≥95% |
| AP15215 | MMAF-methyl ester | 745.99 | ≥98% |
| AP15187 | Doxorubicin-SMCC | 762.8 | ≥98% |
| AP15217 | MMAD | 771.06 | ≥98% |
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:13212737804
邮箱:sales@amyjet.com
0.226